Ariad Pharmaceuticals Inc fka ARIA

[mejs]

Good post from the Yahoo MB September will be an important month 20-Jun-12 11:10 am
In this month we will presumably have three important catalysts.
The first is that, considering a submission of the NDA of Ponatinib to the FDA at the beginning of July, in the first days of september we will know if the agency will grant us a priority review.
The second is that, considering the tendency of Ariad to start its trials in the month of september, we will probably begin the key front line trial of Ponatinib against Gleevec.
The third is that at the end of the month we will hear the first real data on humans of AP26113 at a major oncology meeting.
Consider also that Rida could be approved at any moment in Europe (I remember the case of Intermune in 2010).
Best regards to all longs.